Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome.
Eight of 109 consecutive hyperandrogenic patients had increased serum PRL levels; macroprolactinemia was diagnosed in 4 patients by measuring PRL levels after precipitation of serum with polyethylene glycol, and after detecting macroprolactinemia, these 4 patients were diagnosed with polycystic ovary syndrome (PCOS). Therefore, macroprolactinemia must be ruled out in women presenting with hyperandrogenic symptoms and increased serum PRL concentrations to avoid misdiagnosis (hyperprolactinemia is an exclusion criterion for the diagnosis of PCOS), unnecessary diagnostic tests, and inappropriate use of dopaminergic agonists.
Escobar-Morreale
Héctor F
HF
Department of Endocrinology, Hospital Ramón y Cajal, Madrid, Spain. hescobarm.hrc@salud.madrid.org
D000328:Adult; D003937:Diagnosis, Differential; D005260:Female; D006628:Hirsutism / Q000209:etiology; D006801:Humans; D017588:Hyperandrogenism / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D006966:Hyperprolactinemia / Q000097:blood / Q000150:complications; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D011388:Prolactin / Q000097:blood*; D012189:Retrospective Studies
C060678:prolactin, polymeric; D011388:Prolactin